Recursion Pharmaceuticals (NASDAQ: RXRX), and CRISPR Therapeutics (NASDAQ: CRSP), plunged in March, with the stocks down 35.3 ...
Chinese drug makers landed 33 licensing deals with overseas pharmaceutical firms, with transactions totalling US$36.2 billion ...
KLP Kapitalforvaltning AS acquired a new stake in Biohaven Ltd. (NYSE:BHVN – Free Report) during the fourth quarter, Holdings Channel reports. The institutional investor acquired 16,100 shares of the ...
These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...
More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...